Mkts

Verrica Pharmaceuticals Inc.

NASDAQ: VRCA
$3.42-0.06 (-1.72%)
As of Oct 29, 4:00 PM ET

Key statistics

Day range
3.393.62
52-week range
3.289.82
Today
Open3.48
Previous close3.42
Volume—
Valuation
Market cap63.20M
P/E ratio—
EPS (TTM)-1.67
Income & risk
Dividend / yield—
Beta1.65
Avg volume60.0K
Discussion

VRCA News

Stories mentioning VRCA from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ1 '26Mar 31Q4 '25Dec 31Q3 '25Sep 30Q2 '25Jun 30Q1 '25Mar 31Q4 '24Dec 31Q3 '24Sep 30Q2 '24Jun 30
Income Statement
Revenue5,0235,09214,34412,7023,439344.00(1,781)5,177
Cost of Goods Sold700.00800.00400.00700.00
Gross Profit2,7394,477
Operating Expenses
Research & Development3,8602,5202,2051,8462,2841,1682,4053,319
Sales General & Admin9,9898,1179,4038,8528,8489,87816,08316,522
Total Operating Expenses14,73812,28412,71711,19211,56911,75418,92320,383
Operating Income (Loss)(9,715)(7,192)1,6271,510(8,130)(11,410)(20,704)(15,206)
Interest Income201.00205.00159.00228.00337.00205.00221.00393.00
Interest Expense2,368
Other Expense(8.00)(2.00)0.00(1.00)0.000.00(1.00)(5.00)
Pretax Income
Tax Provision
Net Income (Loss)(9,682)(8,074)(274.00)204.00(9,742)(16,202)(22,860)(17,186)
Earnings Per Share (Basic)(0.45)(0.76)(0.03)0.02(1.03)(3.13)(4.88)(3.70)
Earnings Per Share (Diluted)(0.45)(0.76)(0.03)0.02(1.03)(3.13)(4.88)(3.70)
Weighted Average Shares Outstanding (Basic)21,30510,6529,4909,4889,4845,1814,6814,650
Weighted Average Shares Outstanding (Diluted)21,30510,6529,4909,4919,4845,1814,6814,650

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About VRCA

Verrica Pharmaceuticals Inc. (NASDAQ: VRCA) is a stock listed on the Nasdaq Stock Market under the ticker symbol VRCA. It last traded at $3.42 (Oct 29, 2026, 4:00 PM ET), down 1.7% on the day. That gives Verrica Pharmaceuticals a market capitalisation of $63.2M.

Over the past 52 weeks VRCA has traded between $3.28 and $9.82.

Revenue for the quarter ended Mar 31, 2026 was $5.0M; a net loss of $9.7M. Revenue was up 46.1% from $3.4M in the quarter ended Mar 31, 2025.

Last 4 quarters
Quarter endedRevenueNet incomeMargin
Mar 31, 2026$5.0M-$9.7M-192.8%
Dec 31, 2025$5.1M-$8.1M-158.6%
Sep 30, 2025$14.3M-$274.0K-1.9%
Jun 30, 2025$12.7M$204.0K1.6%

From Verrica Pharmaceuticals’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…